Home » Newsletters » BioWorld Science

BioWorld Science

July 23, 2014

View Archived Issues

Development of a live-attenuated HIV-1 virus incapable of reactivation

Passive immunization against N-terminally truncated beta-amyloid species with NT4X-167 tested

Enrollment open in phase I study of SM-04755 in colorectal, gastric, hepatic or pancreatic cancer

Celladon in-licenses gene therapy application rights for mSCF for cardiac ischemia treatment

MetaMax initiates phase I/IIa study of MM-D37K

Shire recaps progress of second quarter 2014

Cerecor raises funds to support development of pipeline

Sorrento Therapeutics receives NCI grant for Myc inhibitor

NIBIB award supports Celsion's development of ThermoDox for brain tumors

Implantation of cells secreting NGF proves safe in Alzheimer's disease study

Cadila Healthcare discloses new PARP-1 inhibitors

Celon Pharma describes novel PDE9A inhibitors with procognitive potential

Shionogi patents novel cephems

Researchers present phase II data for ELND-005

Roche synthesizes novel COMT inhibitors

Scientists at OriBase Pharma divulge novel protein kinase inhibitors

FDA grants orphan drug status to palovarotene for FOP

European group designs new agents for viral infections

Ganetespib advances into phase III extension of AML LI-1 study

Pierre Fabre presents novel agents for schizophrenia and other disorders

Anavex Life Sciences secures cGMP manufacturing for ANAVEX 2-73

Sage Therapeutics receives fast track designation for SAGE-547

Kyorin signs license agreement with Merck & Co. for vibegron

First phase I trial of JZP-386 begins

Teva acquires Labrys and enhances migraine portfolio

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...